[1]
Ndarabu, “Trial of Immunotherapy in HIV Patients: Our Experience with the Immuno-Modulator Dithiodinicotinic Acid (CPDS) in 34 Congolese Patients”, GJMR, vol. 17, no. K2, pp. 19–26, Jan. 2017.